Study On Optimizing Molecular Testing on Antimicrobial Resistance (IMP gene) - LATAM
Published: 2025-07-30
Finding the Missing IMP Gene: Collaboration UCR and clinical laboratories
Highlights
- Carbapenem resistance is considered one of the greatest current threats to public health.
- Carbapenem resistance in bacteria is mainly due to mechanisms such as the production of carbapenemases (such as the imipenemase IMP, or other enzymes like VIM, NDM, and KPC), that can be detected by several laboratory tests, including immunochromatography and automated real-time PCR (qPCR).
- As part of local studies to monitor carbapenem-resistant bacteria in Costa Rica, two cases were initially identified with inconsistent IMP detection results. A possible gene drop-out in the automated qPCR test was suggested based on the negative result, contrasting with the positive result by immunochromatography and whole-genome sequencing.
- We hypothesized that molecular testing could be optimized through the development of tailored assays to improve the detection of IMP genes.
- Using IMP gene sequences from the local isolates and regional sequences in databases, primers were redesigned to extend the detection of IMP alleles of regional relevance.
- The tailored qPCR was applied to a local collection of 119 carbapenem-resistant isolates. The genomes of all 14 positive cases were sequenced, verifying the results of the custom qPCR, despite the negative results of the automated testing.
- Conclusions: Guided by whole-genome sequencing, it was possible to extend the molecular detection of IMP alleles circulating in Latin America using a tailored qPCR to overcome IMP gene drop-out and false-negative results in an automated qPCR.
Full access: https://www.mdpi.com/2079-6382/14/8/772